---

Market Overview

---

The global parenteral nutrition market exceeded USD 7.18 billion in 2021 and is projected to reach USD 10.70 billion by 2027, growing at a CAGR of 6.88% during the forecast period. The increasing global poverty levels and concerns about nutritional health are key factors driving the demand for parenteral nutrition supply. Market growth is primarily driven by the rising prevalence of malnutrition among hospitalized patients and the general population. Parenteral nutrition is crucial for meeting the nutritional needs of patients who cannot tolerate oral or enteral nutrition delivery. It involves the intravenous administration of carbohydrates, proteins, fats, electrolytes, minerals, vitamins, water, and trace elements.

There are two types of parenteral nutrition: total parenteral nutrition (TPN) and partial parenteral nutrition (PPN). Depending on the patient’s condition and nutritional status, they may receive either total or partial parenteral nutrition in healthcare settings. The parenteral nutrition market is experiencing rapid growth due to increasing awareness about nutritional health, changing lifestyles, and socioeconomic and environmental factors. Innovations and advancements in the field have further fueled market growth.

In recent years, there has been a trend towards personalized and commercial medicine in the healthcare industry. Standardized parenteral nutrition products have gained popularity as they offer convenience and flexibility to healthcare providers. These products can be administered without the need for in-house compounding. They are available as institution-specific standardized formulations, patient-specific customized solutions, or commercially available products. Standardized and commercial parenteral nutrition solutions offer advantages such as stability, compatibility, and minimal manipulation. The demand for these products has been rising due to their associated benefits.

Parenteral nutrition plays a vital role in treating and managing chronic conditions, malnourished populations, and emergency medical situations. The increasing patient population worldwide necessitates nutritional support in various healthcare settings, including hospitals, clinics, and home care. Chronic conditions are a major driver of hospitalization, leading to a higher demand for nutritional support. Furthermore, the prevalence of malnutrition among cancer patients is significant, necessitating external nutrition support. Malnutrition-related deaths among cancer patients underscore the need for parenteral nutrition in this population.

However, there are challenges associated with parenteral nutrition delivery. Complications and inadequate monitoring can hinder the achievement of desired goals. Compared to enteral nutrition, parenteral nutrition receives less prominence due to the higher risk of complications. Infection of the bloodstream and catheter-related issues are primary concerns associated with parenteral nutrition.

The global parenteral nutrition market is experiencing significant growth driven by factors such as increasing poverty rates, concerns about nutritional health, and the rising prevalence of malnutrition. Standardized and commercial parenteral nutrition solutions have gained traction, offering convenience and stability to healthcare providers. Parenteral nutrition plays a crucial role in treating various medical conditions, especially among hospitalized and cancer patients. However, challenges related to complications and inadequate monitoring need to be addressed to enhance the effectiveness of parenteral nutrition delivery.

---

Market Segmentation

---

The market is segmented based on various factors, including nutrients, indication, patient group, end-user, and geography.

Segmentation by Nutrients
Macronutrients
Automated Compounds
Micronutrients

Segmentation by Indication
Short-Term
Long-Term

Segmentation by Patient Group
Pediatric Patient Group
Adult Patient Group

Segmentation by End-users
Hospitals
Ambulatory Care Settings
Others

Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain
APAC – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey

The global parenteral nutrition market is divided into three categories based on the type of nutrients: macronutrients, automated compounds, and micronutrients. In 2021, the macronutrients segment held a higher market share of 66.65% and dominated the other segments. Macronutrients, such as lipids and amino acids, are essential ingredients in parenteral nutrition solutions. They provide energy and support body functions, leading to rapid improvement in physical health. The use of lipids and amino acids in parenteral nutrition is determined by their ability to enhance nutritional health. Furthermore, the extensive availability of macronutrient-based products in the market contributes to the growth of the macronutrient segment.

The global parenteral nutrition market for automated compounds was valued at USD 1.35 billion in 2021. Recent advancements in automated compounds have made them increasingly popular in pediatric parenteral nutrition. Volumetric pump systems are used to automate the compounding of parenteral nutrition in major hospitals and healthcare settings. In the United States, more than 65% of hospitals utilize automated compounding devices.

The parenteral nutrition market is segmented based on patient type into pediatric and adult segments. The pediatric segment holds a major market share of 55.05% and is expected to dominate the adult segment during the forecast period. The demand for parenteral nutrition in pediatric patients is driven by factors such as the significant number of preterm patients, concerns about low birth weight, and malnutrition. Additionally, advancements in trace elements and new products specifically designed for pediatric parenteral nutrition contribute to the growth of this segment.

The global parenteral nutrition market is further divided into short-term and long-term segments based on indication. The short-term segment currently dominates the market with a 55.41% share. Globally, the increasing prevalence of cancer, metabolic disorders, gut failure, and malnutrition significantly contributes to the demand for healthcare services and the need for parenteral nutrition.

In terms of long-term indication, the global parenteral nutrition market was valued at USD 3.20 billion in 2021. Long-term parenteral nutrition is a highly sought-after medical nutrition therapy administered intravenously over an extended period based on the patient’s requirements. The rising prevalence of gastrointestinal disorders and the impact of multiple medications and treatments on the digestive system drive the demand for long-term parenteral nutrition. It takes a significant amount of time for patients to recover from digestive system injuries or surgeries and return to normal health, leading to a high demand for long-term parenteral nutrition.

Among the end-user segments, hospitals accounted for a 47.57% share of the parenteral nutrition market in 2021, establishing their dominance. The increasing prevalence of malnutrition, disease-related malnutrition, and hospital-associated malnutrition significantly contribute to the demand for parenteral nutrition. Hospitals serve as primary and well-established infrastructures for patients requiring extended stays due to medical conditions or procedures. Baxter, the leading industry player, reported that the prevalence of malnutrition in the US involves approximately 2 million hospitals.

The global parenteral nutrition market for ambulatory care settings was valued at USD 3.13 billion in 2021. This segment includes clinics and external healthcare services. In developing countries and emerging markets, malnutrition imposes a significant cost burden on patients. Therefore, patients seeking to avoid lengthy hospital stays opt for other healthcare settings. Clinics and ambulatory care settings play a crucial role in delivering parenteral nutrition in such scenarios. Clinical nutrition is an essential component of healthcare services for patients with chronic illnesses. Additionally, the high cost burden associated with hospital-based parenteral nutrition deliveries and longer stays has led to a shift in patient preferences towards ambulatory care settings.

North America dominates the global parenteral nutrition market, accounting for an industry share of 41.05%. Factors driving industry growth in the region include high research expenditure by companies, government authorities, and private entities in the nutrition sector. This grants the region significant access to parenteral nutrition services. Moreover, the high healthcare expenditure and acceptance of home-based parenteral and other nutrition therapies across the US are expected to drive market growth in the region.

The parenteral nutrition market in the Asia-Pacific region was valued at USD 2.09 billion in 2021. With an aging population, increasing research and development in clinical nutrition, and the growth of regional healthcare infrastructure, the region’s parenteral nutrition market is experiencing continuous growth. The high patient population with chronic disorders such as cancer, diabetes, gastrointestinal disorders, kidney failure, and cardiovascular diseases leads to a growing demand for care services and drives the parenteral nutrition market in the region.

In Europe, the parenteral nutrition market is projected to grow at a CAGR of 6.38% during the forecast period. The region exhibits rapid progressive growth due to factors such as the increasing influence of industry players, heightened focus on parenteral nutrition deliveries by government and healthcare authorities, and a stable economy. The European Society for Clinical Nutrition and Metabolism (ESPEN) is a leading organization in the field of parenteral and enteral nutrition. It supports and promotes basic research, advanced education, and awareness regarding clinical care and quality control.

---

Competitive Landscape

---

Baxter, B. Braun Melsungen, Fresenius Kabi, JW Pharmaceuticals, and Kelun Pharmaceuticals are prominent players in the parenteral nutrition market, holding a significant market share and demonstrating extensive industry penetration through their advanced and high-quality solutions. Concurrently, emerging industry players and start-ups are striving to establish a solid customer base and expand their presence in the market. The presence of these emerging players positively impacts competition within the global parenteral nutrition market. Competition among industry players primarily stems from new product launches and the development of emerging and gold standard formulations.

B. Braun Melsungen is a leading player in the global parenteral nutrition market. On the other hand, Fresenius Kabi specializes in both parenteral nutrition (administered intravenously) and enteral nutrition (administered via tube feeding, sips, or the gastrointestinal tract). Baxter, as a key supplier, provides essential ingredients necessary for the development of well-balanced formulations in parenteral nutrition regimens. The company offers accessible and innovative solutions and services designed for use in various healthcare settings, including hospitals, ICUs, clinics, nursing homes, and home care settings. Additionally, Baxter supplies essential ingredients for the development of well-balanced formulations in medical nutrition regimens.

Key companies profiled in this report include Baxter, B. Braun Melsungen, Fresenius Kabi, JW Pharmaceuticals, Sichuan Kelun Pharmaceuticals, Aculife, Albert David, Amanta Healthcare, American Reagent, BML PARENTERAL DRUGS, Caritas Healthcare, Eurofarma, EuroLife Healthcare Pvt. Ltd., Farmoterapica, Grifol, ICU Medical, Otsuka Pharmaceutical, Soleo Health, REVIV, Pfizer, Vifor Pharma.

---

Key Questions Answered

---

What is the size of the parenteral nutrition market?

The parenteral nutrition market had a global valuation of USD 7.18 billion in 2021 and is projected to reach USD 10.70 billion by 2027.

What is the growth rate of the global parenteral nutrition market?

The global parenteral nutrition market is anticipated to grow at a compound annual growth rate (CAGR) of 6.88% from 2021 to 2027.

Which region dominates the global parenteral nutrition market?

In 2021, North America held a significant parenteral nutrition market share of 41.05% and emerged as the dominant region. This dominance can be attributed to factors such as increased research and development activities in parenteral nutrition solutions, associated expenditures, and government initiatives addressing malnutrition concerns, providing the region with substantial access to parenteral nutrition services.

Who are the major players in the global parenteral nutrition market?

The key players in the global parenteral nutrition market include Baxter, B. Braun Melsungen, Fresenius Kabi, JW Pharmaceuticals, and Sichuan Kelun Pharmaceuticals.

What are the primary drivers behind the growth of the parenteral nutrition market?

The growth of the parenteral nutrition market is driven by factors such as advancements in trace element supplementation for parenteral nutrition, the availability of standardized and commercially prepared parenteral nutrition solutions, and the increasing preference for home-based parenteral nutrition.